Products

NeuroMatch
LVIS Corporation
Neurology AI
NeuroMatch is an AI-powered, cloud-based EEG software platform by LVIS Corporation, designed to assist neurologists in the review, interpretation, and analysis of EEG recordings for enhanced neurological diagnostics and remote collaboration.

See all 1 product →

About LVIS

LVIS Corporation is a pioneering neurotechnology company dedicated to revolutionizing neurological care through advanced AI-driven solutions. Their flagship product, NeuroMatch®, is an AI-powered software-as-a-medical-device platform designed to enhance electroencephalogram (EEG) diagnostics. This platform rapidly analyzes large volumes of brainwave data, transforming raw EEG signals into structured, three-dimensional insights to facilitate faster and more accurate identification of complex neural network patterns. NeuroMatch aims to streamline clinical workflows by automating key aspects of EEG interpretation, including artifact reduction, seizure detection, and spike detection, which are crucial for diagnosing and managing conditions like epilepsy and dementia.

By providing near real-time, objective brainwave measurements and enabling live visualization of brain networks, LVIS empowers physicians to gain deeper insights into neurological disorders. The platform supports more consistent analysis, reduces turnaround times for EEG software interpretation, and facilitates remote collaboration among healthcare professionals. LVIS’s commitment extends to developing digital therapeutics solutions and expanding access to advanced neurological evaluation, particularly in areas affected by neurologist shortages, ultimately aiming to improve patient outcomes through earlier detection and more targeted treatment strategies.

Focus Areas

Neuro care neurological disease diagnosis EEG analysis brain network analysis epilepsy dementia digital twin technology AI-driven solutions ambulatory EEG seizure detection spike detection brain function restoration

Business Intelligence

Key InvestorsSK Networks, SK, APL Ventures, InterVest, A&E Investments, DSC Investment
PartnershipsDaegu Health College (South Korea), Huons Meditech, UCLA (patent licensing), Stanford University (patent licensing), 10 major hospitals in South Korea
TechnologyAI-powered EEG analysis platform, Software as a Medical Device (SaMD), cloud-based, browser-based access, deep learning AI, digital twin technology, source localization
FDA Clearances3 cleared products (estimated)

What Physicians Need to Know

Neurological Disease Diagnosis
LVIS specializes in neuroimaging software that visualizes and analyzes brain networks to diagnose various neurological diseases. Their NeuroMatch platform assists in comprehensive neurological assessments.
Advanced EEG Analysis
The NeuroMatch Access platform is a cloud-based SaaS solution for reviewing, interpreting, and analyzing electroencephalogram (EEG) data. It leverages AI to automate analysis and significantly reduce artifacts, improving data clarity.
Brain Network Analysis
LVIS's technology decodes complex brain networks, providing visualizations that aid in neurological disease diagnosis. NeuroMatch Elite offers advanced computational models for in-depth brain network analysis.
Epilepsy Care
NeuroMatch is a key tool for diagnosing and managing epilepsy. NeuroMatch Elite features precise Seizure Source Localization and Spike Source Localization, offering detailed insights into the origin and network of abnormal brain activity in 3D.
Dementia Solutions
LVIS's NeuroMatch platform analyzes brain networks to diagnose and support treatment strategies for neurological diseases such as dementia, emphasizing early detection and precision care.
Digital Twin Technology
LVIS applies digital twin technology to neurological diagnostics, creating a 'digital twin' of brain activity. This allows clinicians to visualize and track brain activity over time with enhanced clarity, transforming raw EEG signals into structured, three-dimensional insights.
AI-Driven Solutions
At its core, LVIS provides innovative AI-driven solutions for neurological diagnostics and treatment. AI automates EEG analysis, reduces artifacts, and powers advanced features like seizure and spike detection.
Ambulatory EEG Capabilities
The NeuroMatch platform includes advanced ambulatory EEG capabilities, streamlining the review of continuous brain activity recorded over several days. AI processes large datasets, detects neurological events, and filters out common artifacts.
Seizure Detection & Localization
NeuroMatch offers AI-powered Seizure Detection using deep-learning algorithms to automatically identify seizure events. NeuroMatch Elite provides precise Seizure Source Localization, pinpointing the origin of seizures in 3D.
Spike Detection & Localization
The platform incorporates AI-powered Spike Detection to identify spikes and sharp wave events, crucial for epilepsy diagnosis and management. NeuroMatch Elite further offers precise Spike Source Localization.
Brain Function Restoration
A primary goal of LVIS's approach is to restore brain function. Their technology facilitates targeted interventions and restorative strategies by making intricate brain functions visible for diagnosis and treatment.
Physician Tip

LVIS's NeuroMatch platform is designed to significantly enhance neurological care by offering faster, more confident diagnoses through AI-driven EEG analysis and artifact reduction. Physicians can benefit from reduced manual review burden, especially with ambulatory EEGs, as the system automatically flags relevant events. The platform provides unprecedented visualization of brain circuits and 3D source localization for seizures and spikes, enabling more targeted and effective treatment plans. Its cloud-based, web-accessible nature allows for remote accessibility and real-time collaboration, addressing the neurologist shortage and expanding access to specialized care. Furthermore, NeuroMatch integrates seamlessly into existing clinical workflows without requiring additional hardware, and its FDA clearance provides regulatory assurance. Longitudinal patient reports allow for tracking patient progress over time, supporting comprehensive care.

The NeuroMatch platform is built as a cloud-based SaaS, ensuring accessibility and scalability. It is designed to integrate with standard EEG file formats and existing hospital hardware, fitting within current clinical workflows. The cloud infrastructure also supports seamless collaboration among healthcare teams across multiple facilities.

Products by LVIS

1 product in the directory

NeuroMatch
LVIS Corporation
Neurology AI
NeuroMatch is an AI-powered, cloud-based EEG software platform by LVIS Corporation, designed to assist neurologists in the review, interpretation, and analysis of EEG recordings for enhanced neurological diagnostics and remote collaboration.

What the Web Says

LVIS (likely referring to LVIS, Inc., a healthcare IT company) receives mixed reviews. While some users praise its product's functionality and customer support, others express concerns about pricing, implementation challenges, and the company's work environment. Employer reviews indicate a generally positive culture but highlight areas for improvement in management and work-life balance.

Overall: Mixed

Strengths

  • Good product functionality for specific healthcare needs
  • Responsive customer support
  • Positive company culture (employer reviews)
  • Helpful for data management in healthcare
  • User-friendly interface (for some products)
  • Dedicated and knowledgeable staff

Limitations

  • High pricing for some solutions
  • Challenging or lengthy implementation process
  • Occasional software bugs or glitches
  • Management issues and lack of clear direction (employer reviews)
  • Work-life balance concerns (employer reviews)
  • Limited features in certain product versions

Based on reviews from: G2, Glassdoor, Capterra, Healthcare IT Reviewers (general), Reddit

Last updated: 2026-07-18

Videos

News, demos, and interviews about LVIS.

Loading videos...

Videos load interactively. If none appear, search YouTube for LVIS →

View all on YouTube

Press & Coverage

MPO Magazine
LVIS Corporation Unveils Cloud-Based Platform for EEG Diagnostics
LVIS Corporation launched NeuroMatch Access, a cloud-based SaaS platform utilizing AI to streamline EEG diagnostics, enhance physician collaboration, and provide fast, accurate interpretation of EEG data. The platform is now available in the United States, following a successful launch in South Korea where it was installed in 10 top hospitals.
2024-12
MLO Online
LVIS Corporation launches AI platform that simplifies ambulatory review for effortless clinical workflows | MLO Online
LVIS Corporation has enhanced its NeuroMatch platform with full ambulatory EEG capability, allowing healthcare providers to launch, monitor, and interpret ambulatory EEG studies from any internet-connected device. The AI-powered platform analyzes large datasets, identifies neurological events, and filters artifacts in a browser-based interface.
2025-08
IMA Network
LVIS Corporation Receives Artificial Intelligence Excellence Award for NeuroMatch - IMA Network
LVIS Corporation received the 2026 Artificial Intelligence Excellence Award in the Digital Twin Technology category for its NeuroMatch platform, an AI-powered EEG software that creates a digital twin of brain activity. This award recognizes organizations advancing the real-world application of AI across industries.
2026-04
LVIS Corporation
LVIS Corporation Receives Silver Award Recognition at the 2026 Edison Awards for AI-Powered Neurological Diagnostics
LVIS Corporation was honored with a Silver Winner award at the 2026 Edison Awards for its advancements in AI-powered neurological disease detection. The recognition highlights the company's efforts to improve diagnostic efficiency and support physicians in interpreting complex brain network activity.
2026-04
IMA Network
LVIS Corp Set to Revolutionize Epilepsy Diagnosis and Treatment with Launch of FDA Approved NeuroMatch Elite - IMA Network
LVIS Corp announced the upcoming U.S. release of NeuroMatch Elite, an FDA-approved platform with Seizure Source Localization and Spike Source Localization capabilities to revolutionize epilepsy care. This technology offers precise 3D localization of abnormal brain activity, moving beyond traditional EEG analysis.
2025-06
BioWorld
LVIS launches Neuromatch Access in US, Korea as EEG diagnostic | BioWorld
LVIS Corp. launched its cloud-based NeuroMatch Access platform as a software as a service (SaaS) to assist neurologists in reviewing, interpreting, and analyzing EEG data. The company has secured key regulatory approvals for NeuroMatch in both the U.S. and Korea, including FDA clearance in June 2023.
2025-01
IMA Network
EEG Breakthrough: LVIS Corporation Launches AI Platform That Simplifies Ambulatory Review for Effortless Clinical Workflows - IMA Network
LVIS Corporation has significantly enhanced its NeuroMatch platform with full ambulatory EEG capability, aiming to streamline the often cumbersome process of diagnosing complex neurological conditions like epilepsy. The AI-powered platform efficiently analyzes large datasets, identifies neurological events, and filters artifacts through a browser-based interface.
2025-08
Journal of Clinical Medicine (MDPI)
Initial Experience with LVIS EVO Stents for the Treatment of Intracranial Aneurysms - MDPI
This peer-reviewed article details the initial positive experience with LVIS EVO stents for treating intracranial aneurysms in 30 patients between February and September 2020. The study highlights the successful deployment of all stents and the effectiveness of stent-assisted coil embolization.
2020-12

Frequently Asked Questions

LVIS NeuroMatch is a cloud-based, AI-driven software platform designed to streamline EEG data analysis for neurologists and medical professionals. It enhances neurological disease diagnosis by providing rapid and accurate identification of complex neural network patterns, visualizing brain circuits, and reducing artifacts in EEG signals. This allows for quicker, more comprehensive results and supports targeted care strategies for various brain conditions.
LVIS leverages AI to automate EEG analysis, identify seizure activity and spikes, and filter out artifacts like muscle movements, significantly accelerating the review process. The company's founder developed the platform based on research related to a 'digital twin' of the brain, aiming to directly measure brain circuit communication to facilitate brain function restoration. This approach helps clinicians visualize and understand intricate communication pathways for improved diagnosis and treatment.
NeuroMatch is designed to detect neurological disorders such as seizures and memory problems, with specific capabilities for identifying seizure activity and spikes in EEG data. The platform also offers full ambulatory EEG functionality, streamlining the review of continuous brain activity recordings over several days, which is crucial for diagnosing conditions like epilepsy. LVIS plans to expand its diagnostic products to include solutions for Alzheimer's disease, autism, Parkinson's disease, and sleep disorders.
LVIS's NeuroMatch Access platform is a HIPAA-compliant service, ensuring the protection of patient health information. The company has also achieved ISO 13485 certification, a globally recognized standard for quality management systems in medical devices, demonstrating its commitment to delivering safe, reliable, and high-performing solutions. These measures underscore LVIS's dedication to data security and adherence to healthcare regulatory requirements.
LVIS offers NeuroMatch Access as a subscription-based service, aiming to provide a scalable and cost-effective solution for neurological care. For support, LVIS provides assistance for NeuroMatch sales, general support, and educational initiatives through its NeuroMatch Academy. The company has established partnerships with institutions like UCLA and Stanford for exclusive patent licensing, and collaborates with educational hubs like Daegu Health College for training healthcare professionals.
Founded in 2013, LVIS Corporation is a privately held company with a strong track record, having raised $73.8 million in funding through various rounds, including later-stage venture capital. The company has successfully launched NeuroMatch in South Korea, installing it in 10 leading hospitals, and has expanded its presence to the U.S. LVIS has also received an Artificial Intelligence Excellence Award and was named a finalist for the 2026 Edison Awards, indicating its innovation and stability in the healthcare AI industry.

Related Companies

Visiopharm is a leading provider of AI-driven precision pathology software, catering to both research and diagnostic applications. For physicians, Visiopharm offers advanced tools that transform pathology through image analysis, aiming to enhance precision and productivity in pathology labs. The company has developed nine diagnostic algorithms cleared under IVDR for EU and UK customers, which provide […]

TSI (Transworld Systems Inc.) is a long-standing company primarily known for its debt collection and business process outsourcing services. While they serve various industries, including healthcare, their core offering is focused on accounts receivable management and collections rather than healthcare-specific AI development. They provide solutions to help healthcare providers manage patient accounts, improve cash flow, […]

TrialX is a healthcare AI company specializing in clinical research and space health informatics. The company develops platforms designed to connect patients with clinical trials and facilitate research data collection. Their offerings include an enterprise patient recruitment platform (iConnect) that provides a clinical trials finder (Dory), study website builders, pre-screeners, referral tracking, and volunteer registries. […]

Thinkitive is a global IT services and solutions company that specializes in digital transformation, enterprise application services, outsourced product development, and a testing center of excellence. For physicians, Thinkitive offers a range of AI-driven healthcare solutions designed to streamline clinical and administrative workflows, enhance patient care, and improve operational efficiency. Their services include custom healthcare […]

Taction Software is a U.S.-based healthcare IT and custom software development company specializing in HIPAA-compliant solutions. They build AI-powered applications for healthcare, ranging from rapid clinical AI prototypes to production-grade systems with EHR integration, ambient documentation, and predictive analytics. The company focuses on transforming healthcare delivery through secure, compliant, and innovative software solutions that aim […]

SUPERWISE offers an enterprise AI governance and operations platform designed to help organizations, including those in healthcare, deploy and manage autonomous AI systems with oversight and control. The platform addresses governance, compliance, and operational challenges associated with AI and machine learning deployments. It features real-time guardrails for AI systems, model observability capabilities, and compliance automation, […]

AI Tool Finder
AI-powered search. Results may not be comprehensive.